Guided Therapeutics (GTHP) Prepaid Assets (2010 - 2025)
Guided Therapeutics recorded quarterly Prepaid Assets of $90000.0 in Q4 2025, down 26.83% quarter-over-quarter from $123000.0 in Q3 2025, and down 47.98% year-over-year from $173000.0 in Q4 2024.
Guided Therapeutics' Prepaid Assets history runs 16 years deep, the most recent figure standing at $90000.0 for Q4 2025.
- In Q4 2025, Prepaid Assets fell 47.98% year-over-year to $90000.0; the TTM figure through Dec 2025 stood at $90000.0 (down 47.98% YoY), while the FY2025 annual figure was $90000.0, down 47.98% from the prior year.
- Prepaid Assets came in at $90000.0 for Q4 2025 at Guided Therapeutics, down from $123000.0 in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $453000.0 in Q1 2022 to a low of $23000.0 in Q2 2025.
- A 5-year average of $149200.0 and a median of $130000.0 in 2022 frame the typical range for Prepaid Assets.
- Across the five-year window, Prepaid Assets jumped 1061.54% in 2022 and sank 79.46% in 2025, its largest moves.
- Guided Therapeutics' Prepaid Assets stood at $377000.0 in 2021, then sank by 63.66% to $137000.0 in 2022, then gained by 18.98% to $163000.0 in 2023, then grew by 6.13% to $173000.0 in 2024, then plunged by 47.98% to $90000.0 in 2025.
- According to Business Quant data, Prepaid Assets over the past three periods registered $90000.0, $123000.0, and $23000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Guided Therapeutics | - | - | 458,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 90,000.00 |
| Sep 30, 2025 | 123,000.00 |
| Jun 30, 2025 | 23,000.00 |
| Mar 31, 2025 | 61,000.00 |
| Dec 31, 2024 | 173,000.00 |
| Sep 30, 2024 | 211,000.00 |
| Jun 30, 2024 | 112,000.00 |
| Mar 31, 2024 | 156,000.00 |
| Dec 31, 2023 | 163,000.00 |
| Sep 30, 2023 | 192,000.00 |
| Jun 30, 2023 | 91,000.00 |
| Mar 31, 2023 | 121,000.00 |
| Dec 31, 2022 | 137,000.00 |
| Sep 30, 2022 | 169,000.00 |
| Jun 30, 2022 | 59,000.00 |
| Mar 31, 2022 | 453,000.00 |
| Dec 31, 2021 | 377,000.00 |
| Sep 30, 2021 | 173,000.00 |
| Jun 30, 2021 | 61,000.00 |
| Mar 31, 2021 | 39,000.00 |
| Dec 31, 2020 | 85,000.00 |
| Sep 30, 2020 | 110,000.00 |
| Jun 30, 2020 | 41,000.00 |
| Mar 31, 2020 | 36,000.00 |
| Dec 31, 2019 | 70,000.00 |
| Sep 30, 2019 | 106,000.00 |
| Jun 30, 2019 | 2,000.00 |
| Mar 31, 2019 | 36,000.00 |
| Dec 31, 2018 | 69,000.00 |
| Sep 30, 2018 | 108,000.00 |
| Jun 30, 2018 | 41,000.00 |
| Mar 31, 2018 | 90,000.00 |
| Dec 31, 2017 | 111,000.00 |
| Sep 30, 2017 | 179,000.00 |
| Jun 30, 2017 | 356,000.00 |
| Mar 31, 2017 | 206,000.00 |
| Dec 31, 2016 | 259,000.00 |
| Sep 30, 2016 | 463,000.00 |
| Jun 30, 2016 | 502,000.00 |
| Mar 31, 2016 | 509,000.00 |
| Dec 31, 2015 | 780,000.00 |
| Sep 30, 2015 | 979,000.00 |
| Jun 30, 2015 | 28,000.00 |
| Mar 31, 2015 | 52,000.00 |
| Dec 31, 2014 | 99,000.00 |
| Sep 30, 2014 | 431,000.00 |
| Jun 30, 2014 | 13,000.00 |
| Mar 31, 2014 | 48,000.00 |
| Dec 31, 2013 | 101,000.00 |
| Sep 30, 2013 | 185,000.00 |
| Jun 30, 2013 | 115,000.00 |
| Mar 31, 2013 | 247,000.00 |
| Dec 31, 2012 | 198,000.00 |
| Sep 30, 2012 | 119,000.00 |
| Jun 30, 2012 | 39,000.00 |
| Mar 31, 2012 | 45,000.00 |
| Dec 31, 2011 | 54,000.00 |
| Jun 30, 2011 | 22,000.00 |
| Dec 31, 2010 | 30,000.00 |